Objective-Smooth muscle cell (SMC) migration and proliferation play an essential role in neointimal formation after vascular injury. In this study, we intended to investigate whether the X-box-binding protein 1 (XBP1) was involved in these processes. Approach and Results-In vivo studies on femoral artery injury models revealed that vascular injury triggered an immediate upregulation of XBP1 expression and splicing in vascular SMCs and that XBP1 deficiency in SMCs significantly abrogated neointimal formation in the injured vessels. In vitro studies indicated that platelet-derived growth factor-BB triggered XBP1 splicing in SMCs via the interaction between platelet-derived growth factor receptor β and the inositolrequiring enzyme 1α. The spliced XBP1 (XBP1s) increased SMC migration via PI3K/Akt activation and proliferation via downregulating calponin h1 (CNN1). XBP1s directed the transcription of mir-1274B that targeted CNN1 mRNA degradation. Proteomic analysis of culture media revealed that XBP1s decreased transforming growth factor (TGF)-β family proteins secretion via transcriptional suppression. TGF-β3 but not TGF-β1 or TGF-β2 attenuated XBP1s-induced CNN1 decrease and SMC proliferation. Conclusions-This study demonstrates for the first time that XBP1 is crucial for SMC proliferation via modulating the platelet-derived growth factor/TGF-β pathways, leading to neointimal formation. under stress conditions. [21] [22] [23] Under ER stress conditions, XBP1 mRNA undergoes unconventional splicing through an ER-resident kinase that possesses ribonuclease activity, the inositol-requiring enzyme 1 α (IRE1α). 24 Our recent studies and reports from other groups showed that physiological stimuli such as vascular endothelial cell growth factor could trigger XBP1 splicing in an ER stress response-independent manner. [25] [26] [27] [28] In endothelial cells (ECs), XBP1 splicing plays diverse roles, including cell proliferation, 26 autophagy response, 29 and apoptosis. 30 In SMCs, bone morphogenetic protein-2 was reported to activate XBP1 splicing, 31 but the exact role of XBP1 in SMCs still remains unclear. In this study, we demonstrated that XBP1 splicing is crucial in PDGF-BB-induced SMC proliferation and contributes to neointima formation after vascular injury.
S mooth muscle cells (SMCs) are the main cell components in the media of the vessel wall, maintaining the blood vessel tone and pressure. Hyperplasia of SMCs contributes to vascular disease, such as stenosis and atherosclerosis. 1, 2 Although the origin of SMCs in the lesion area is controversial, [3] [4] [5] [6] SMC migration and proliferation play a central role in disease development. Multiple cytokines or growth factors have been documented to regulate SMC migration and proliferation, 2, 7, 8 in which platelet-derived growth factor (PDGF) and transforming growth factor-β (TGF)-β play important roles. For stem/ progenitor cells differentiation toward SMC lineage, PDGF functions as a differentiation stimulus. 9 In mature SMCs, PDGF functions as a mitogenic factor, triggering SMC dedifferentiation, migration and proliferation. 5, 10 Several signaling pathways activated by PDGF in SMC have been reported, including PI3K/Akt, endoplasmic reticulum kinase (ERK), c-Jun, and basic fibroblast growth factor release. 11, 12 However, the detailed mechanism on how PDGF receptor activation results in adaptor protein binding is still unclear.
TGF-β is a superfamily of multiple growth factors, including TGF-β1 to TGF-β3, bone morphogenetic proteins, and connective tissue growth factor. 13 TGF-βs can be secreted by almost all cell types, including SMCs, functioning in an autocrine, paracrine, or endocrine manner. Different types of TGFβs exert different functions in different cell types. On SMCs, TGF-β1 suppresses proliferation while induces differentiation.
14,15 TGF-β2 plays an essential role in the valve formation during embryonic development via endothelial-mesenchymal transition. 16 TGF-β3 negatively regulates TGF-β1-mediated extracellular matrix deposition. 17 During SMC differentiation, the upregulation of calponin h1 (CNN1) expression was observed. Reduced level of CNN1 was observed in human uterine leiomyosarcoma, whereas increasing CNN1 suppressed leiomyosarcoma cell proliferation. 18 Overexpression of CNN1 could suppress SMC proliferation and neointima formation. 19, 20 The X-box-binding protein 1 (XBP1) was originally identified as a stress-inducible transcription factor in both invertebrate and vertebrate cells, and essential for cell survival under stress conditions. [21] [22] [23] Under ER stress conditions, XBP1 mRNA undergoes unconventional splicing through an ER-resident kinase that possesses ribonuclease activity, the inositol-requiring enzyme 1 α (IRE1α). 24 Our recent studies and reports from other groups showed that physiological stimuli such as vascular endothelial cell growth factor could trigger XBP1 splicing in an ER stress response-independent manner. [25] [26] [27] [28] In endothelial cells (ECs), XBP1 splicing plays diverse roles, including cell proliferation, 26 autophagy response, 29 and apoptosis. 30 In SMCs, bone morphogenetic protein-2 was reported to activate XBP1 splicing, 31 but the exact role of XBP1 in SMCs still remains unclear. In this study, we demonstrated that XBP1 splicing is crucial in PDGF-BB-induced SMC proliferation and contributes to neointima formation after vascular injury.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Vascular Injury Increased XBP1 Expression and Splicing
In response to vascular injury, vascular SMCs will be activated undergoing migration, proliferation, and apoptosis. 32 To test whether XBP1 was involved in SMC activation, femoral artery injury model was introduced into the right side of C57Bl/6 mice. The injured vessels were harvested at day 1, and day 3 post surgery, whereas the left uninjured vessels were collected as control. Double immunofluorescence staining with anti-α SMC actin and antispliced XBP1 (XBP1s) or unspliced XBP1 (XBP1u) antibodies were performed on the cryo-sections. As shown in Figure 1A , low levels of XBP1s and XBP1u were detected in the uninjured vessels, but much higher levels of both XBP1s and XBP1u could be detected at the media layer in the injured vessels at days 1 or 3 time points. ECs were observed in the endothelium layer and the adventitia area of the uninjured vessels at days 1 and 3 as revealed by CD31 staining ( Figure 1A ). There were CD31-positive cells in the adventitia area but not in the endothelium layer of the injured vessels at both days 1 and 3 ( Figure 1A ).
To further quantitatively compare the expression level of XBP1s to that of XBP1u, Reverse transcriptase polymerase chain reaction (RT-PCR)/PstI digestion assays were performed, using RNA extracted from the vessels. There is a PstI restriction enzyme site in the 26 nucleotides intron of the XBP1u mRNA, removal of this intron by unconventional splicing will destroy the PstI site. Therefore, the digestion of the RT-PCR product with a primer set flanking the intron can distinguish XBP1u (digested) from XBP1s (undigested). A schematic illustration of the primer set and the PstI site was presented in Figure IA in the online-only Data Supplement. The vascular injury immediately upregulated XBP1 transcription at day 1, but decreased at day 7 and increased again at later stage ≤28 days ( Figure IB in the online-only Data Supplement). The XBP1 splicing was continuously maintained at higher levels post injury (S/U ratio in Figure IB in the online-only Data Supplement). These results suggest that vascular injury can activate XBP1 expression and especially splicing in vascular SMCs.
The XBP1 Gene Disruption in SMCs Reduced Neointima Formation
To study the role of XBP1 in injury-induced neointima formation, XBP1 loxP/loxP mice were generated by gene targeting 26 and crossbred with SM22-Cre transgenic mice to create SMC conditional knockout mice, that is, SM22-Cre ), the lumen area was larger, whereas the intima area and the ratio of intima to media were significantly decreased ( Figure 1D ). These results suggest that XBP1 expression and splicing in SMCs plays a role in neointimal formation.
PDGF-BB Activated XBP1 Splicing
As indicated above, fewer SMCs were observed in the neointimal lesions in the XBP1 conditional knockout mice. Vascular injury can trigger platelet aggregation, releasing PDGF in the injured area. 33 PDGF has been demonstrated to be one of the major mitogenic growth factors for adult SMC proliferation. Therefore, we wondered whether the vascular injury-induced XBP1 splicing was activated by PDGF. To test this, PDGF-BB was added to human aortic SMCs, followed by IRE1α phosphorylation and XBP1 splicing assessments. As shown in Figure 2A , PDGF-BB treatment transiently increased XBP1 splicing with a peak at 30 minutes. IRE1α/ XBP1 splicing is 1 of the 3 major signaling pathways activated by ER disturbance. 34, 35 To test whether PDGF activated XBP1 splicing through the ER stress response, an ER stress inducer, thapsigargin, was included. As expected, the thapsigargin treatment for 4 hours induced IRE1α phosphorylation, XBP1 splicing, activating transcription factor 6 cleavage (precursor band decrease) and protein kinase R (PKR)-like ER kinase phosphorylation ( Figure 2B) , showing a typical ER stress response. However, PDGF treatment only activated IRE1α phosphorylation and XBP1 splicing without activation of the other 2 signaling pathways ( Figure 2B ), suggesting that PDGF may activate XBP1 splicing in an ER stress responseindependent manner.
Our previous study and others reported that vascular endothelial cell growth factor activated XBP1 splicing through vascular endothelial cell growth factor receptor interaction with IRE1α. 26, 27 To test whether a similar mechanism was involved, the interaction between PDGF receptor β (PDGFRβ) and IRE1α was first assessed by immunoprecipitation. Indeed, PDGFRβ physically interacted with IRE1α, which was enhanced by the presence of PDGF-BB ( Figure 2C ). PDGF treatment increased IRE1α phosphorylation at Ser724 site ( Figure 2C ). Glucose response protein 78 (grp78) is a chaperone molecule, associating with IRE1α under normal conditions. In response to different stimuli, IRE1α phosphorylation can be activated via grp78/IRE1α dissociation dependent or ) mice (B and C). The left side uninjured vessels were collected as control. A, Vascular injury activated X-box-binding protein 1 (XBP1) expression and splicing. Double immunofluorescence staining were performed on days 1 and 3 vessel cryo-sections with anti-smooth muscle actin (SMA) (red), anti-CD31 (red), anti-XBP1s (green), or anti-unspliced XBP1 (green) antibodies. 4′,6-diamidino-2-phenylindole was used to counterstain the nucleus. B-D, XBP1 deficiency in smooth cell muscle decreased the neointima formation. Four weeks post femoral artery injury, the injured vessels and the left side uninjured vessels were harvested and sectioned, followed by hematoxylin and eosin staining (B), double immunofluorescence staining with anti-SMA (red) and anti-XBP1s (green) (C, arrowheads showed the elastin) and analysis of the average luminal area, intima area, and the ratio of intima/media from 6 mice for each group (D). Data presented were representative images or mean of the numbers indicated. *P<0.05. independent way. 36, 37 To test whether PDGF also induced the dissociation of grp78 and IRE1α, grp78 was detected in the immunoprecipitation samples. Indeed, PDGF increased the dissociation of grp78 and IRE1α ( Figure 2C ). As grp78 can bind immunoglobulin, 38 a small amount of grp78 could be detected in the IgG control. The interaction of PDGFRβ and IRE1α was further confirmed by immunofluorescence staining ( Figure 2D ). To define the binding domain in PDGFRβ, the truncated HA-tagged PDGFRβ plasmids were created ( Figure 
XBP1 Splicing Was Related to SMC Migration and Proliferation
PDGF triggers SMC migration and proliferation. 39 The above data have shown that PDGF can activate XBP1 splicing. To explore whether XBP1 splicing is involved in PDGF-induced SMC migration and proliferation, cell counting-based proliferation and transwell-based migration assays were performed. Overexpression of XBP1s by adenovirus (Ad)-XBP1s gene transfer increased SMC proliferation by 20% when compared with that by Ad-null or Ad-XBP1u gene transfer ( Figure 3A) . However, the knockdown of XBP1 (XBP1sh) or decreased XBP1 splicing via knockdown of IRE1α (IRE1αsh) reduced SMC proliferation ( Figure 3B ) and abolished PDGF-induced SMC proliferation ( Figure 3C mice not only reflected the suppressive effect on SMC proliferation but also might reflect the decrease of migration. To test this, we first observed the effect of overexpression of XBP1 on SMC migration, using a transwell model. As shown in Figure 3D , overexpression of XBP1s but not XBP1u dramatically increased SMC migration. However, further experiments with SMCs isolated from XBP1 loxP/loxP (XBP1
+/+
) and SM22-Cre
) mice revealed that overexpression of XBP1s had similar effect on the migration of both cell types and that there was no significant difference in the response to PDGF ( Figure 3E ), suggesting that XBP1 was not necessary for PDGF-induced SMC migration. These results suggest that XBP1 splicing can activate SMC migration and proliferation but is only essential for PDGF-induced proliferation.
XBP1s Increased SMC Migration Via the PI3K/Akt Pathway
It has been reported that PDGF stimulates SMC migration and proliferation through activation of multiple kinases, such as the PI3K/Akt, 40 MEK-ERK, 41 JNK, 42 and p38 43 pathways. The above data indicate that activation of XBP1 splicing is sufficient to induce SMC migration and proliferation, although it is not necessary for PDGF-induced migration. To test which signaling pathway was involved in XBP1s-induced SMC migration and proliferation, the Akt, ERK, c-jun, and p38 phosphorylation were assessed after the overexpression of XBP1s. As shown in Figure VA in the online-only Data Supplement, XBP1s but not XBP1u could activate Akt phosphorylation; ERK phosphorylation was decreased by XBP1s, and there was no change on c-jun and p38 phosphorylation. These results suggest that the PI3K/Akt pathway may be involved. The immunoprecipitation assays revealed that in the presence of XBP1s, more Akt was associated with PI3K ( Figure VB in the online-only Data Supplement) and that XBP1s, Akt, and PI3K formed a complex ( Figure VC in the online-only Data Supplement). These results suggest that XBP1s can activate the PI3K/Akt signaling pathway. To test whether the PI3K/Akt pathway was involved in XBP1s-induced SMC proliferation and migration, the PI3K/Akt inhibitor LY294002 was included in the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)-based proliferation and the transwell-based migration assays. Interestingly, LY294002 had no effect on XBP1s-induced cell proliferation ( Figure VD in the online-only Data Supplement) but significantly suppressed XBP1s-induced SMC migration ( Figure  VE in the online-only Data Supplement), suggesting that the PI3K/Akt signaling pathway is only involved in SMC migration. As XBP1 deficiency had no effect on PDGF-induced SMC migration, we wondered whether XBP1 was involved in PDGF-induced PI3K/Akt activation. As expected, Western blot analysis revealed that XBP1 deficiency had no effect on PDGFinduced Akt phosphorylation although the total Akt protein level was decreased in the XBP1-deficient cells ( Figure VF in the online-only Data Supplement). These results suggest that XBP1s may be sufficient but not necessary to activate the PI3K/ Akt signaling pathway that contributes to XBP1s-induced SMC migration and that XBP1s-induced SMC migration, and proliferation are regulated by 2 different pathways.
XBP1s Increased SMC Proliferation Through Downregulation of CNN1
In addition to PI3K/Akt activation, it has been reported that downregulation of CNN1 plays an important role in SMC proliferation. 44 Western blot analysis showed that XBP1s decreased CNN1 and myocardin protein levels but had no effect on α-SMC actin and serum response factor ( Figure 4A suggesting that CNN1 in SMC is regulated by some secreted factors, which are affected by XBP1s. To confirm the involvement of CNN1 in XBP1s-induced SMC proliferation, we created an Ad-CNN1 viral vector. The coinfection of SMC with Ad-XBP1s and Ad-CNN1 attenuated Ad-XBP1s-induced SMC proliferation ( Figure 4B ). Although LY294002 suppressed XBP1s-induced SMC migration, it had no effect on SMC proliferation. As expected, LY294002 had no effect on XBP1s-induced CNN1 decrease ( Figure VIB in the online-only Data Supplement). Further experiments demonstrated that PDGF downregulated CNN1 in human aortic SMCs ( Figure 4C ) and the cultured mouse arterial SMCs ( Figure 4D ), which required functional IRE1α and XBP1. SMCs isolated from XBP1 −/− mice showed retarded proliferation. The CNN1 level in XBP1 −/− SMCs was dramatically higher than that in wildtype SMCs ( Figure 4D ; Figure VIC in the online-only Data Supplement). These results suggest that XBP1s may promote SMC proliferation through downregulating CNN1.
XBP1s Downregulated CNN1 Via mir-1274B-
Mediated mRNA Degradation
The decrease of a protein level can be derived from decreased biosynthesis due to decreased mRNA level, or increased posttranslational degradation. To explore how XBP1s downregulated CNN1 protein, we first checked the CNN1 mRNA level.
Quantitative RT-PCR analysis showed that overexpression of XBP1s decreased the CNN1 mRNA level in a time-dependent manner ( Figure 5A ). Considering that XBP1s is an intact transcription factor, we wondered if XBP1s downregulated CNN1 transcription. A 1.3-kb CNN1 gene promoter containing partial exon 1 was amplified by PCR and cloned into pGL3-Luc reporter system. Compared with pGL3-Luc control vector, pGL3-CNN1-Luc vector gave rise to high level of luciferase activity in SMCs (30-fold, Figure and mir-18a expression and secretion. Quantitative polymerase chain reaction was performed to analyze the mir-1274B and mir-18a in the cellular RNAs or RNAs isolated from conditioned media. E, Pre-mir-1274B and not pre-mir-18a decreased CNN1 mRNA in transfected smooth cell muscles. Control pre-mir (ctl) was included. F, Platelet-derived growth factor (PDGF) increased the binding of XBP1s to the −520 to −290 region in mir-1274B promoter as revealed by the anti-XBP1s (α-1s) antibody-mediated chromatin immunoprecipitation assay. Normal IgG and anti-XBP1u (α-1u) were included. Arrow showed the transcription initiation site and direction, arrowheads showed the position of the primer set. Data presented were representative images or mean of 3 independent experiments. Fold of induction was defined as data from the test group was normalized to that of the control group that was set as 1.0. *P<0.05; **P<0.01. grp78-luc reporter system, overexpression of XBP1s increased the reporter expression more than 9-fold as compared to the mock vector. Therefore, we assumed that XBP1s had no effect on pGL3-CNN1-Luc reporter expression. These results suggest that XBP1s-induced decrease of CNN1 may not be through the transcriptional suppression. However, as the cloned reporter is only 1.3-kb, we cannot exclude that XBP1s may suppress CNN1 transcription through a distal enhancer element.
As XBP1s exerted no inhibitory effect on CNN1 transcription, the decrease of CNN1 mRNA might be derived from mRNA degradation. The mRNA stability is mainly regulated by the cis-elements in the 3′ terminal untranslated region (UTR). 45 To test this, the 520-bp fragment of the 3′-UTR was amplified and cloned into pSi-check2 vector (Promega), designated as pSI-CNN1 ( Figure VIIB in the online-only Data Supplement). The pSi-check2 (mock) vector or pSI-CNN1 was cotransfected with pShuttle2-XBP1s vector, followed by the reporter analysis. As expected, the insertion of CNN1 3′-UTR significantly reduced the ratio of the Renilla/Firefly luciferase activities ( Figure 5B ). Overexpression of XBP1s significantly increased pSI-check2 vector and decreased pSI-CNN1 reporter activity ( Figure 5B ). Further experiments revealed that PDGF treatment also decreased the reporter activity of pSI-CNN1, which was blocked by knockdown of XBP1 or IRE1α ( Figure VIIIA in the online-only Data Supplement). These results suggest that there may be some XBP1s-regulated trans-elements that bind to the cis-elements in 3′-UTR, leading to CNN1 mRNA degradation.
MicroRNAs (miRNAs) play an important role in the mRNA stability. 46 To explore whether the XBP1s-regulated trans-elements were miRNAs, miRNA arrays were performed, using Taqman miRNA A/B cards from Life Technologies. A total of 764 miRNAs were analyzed. The XBP1s-regulated miRNAs with 2-fold of changes were listed in Figure VIIIB in the online-only Data Supplement. Through the electronic analysis of the potential miRNA target sequences with RNAwalk software, we found that mir-18a (1570-1586, NM_001299) and mir-1274B (1226-1239 and 1239-1242, NM_001299) had 1 and 2 potential-binding sites in the 3′-UTR of CNN1 mRNA, respectively ( Figure 5C ). Quantitative RT-PCR analysis confirmed that overexpression of XBP1s increased both mir-18a and mir-1274B expression (Figure 5D left) . The analysis of miRNAs in cell culture medium revealed that XBP1s also increased the secretion of these 2 miRNAs (Figure 5D right) . Transfection of SMCs with miRNA mimics showed that mir-1274B but not mir-18a decreased the CNN1 mRNA level ( Figure 5E ), suggesting that mir-1274B is involved in CNN1 mRNA stability regulation. With the pSI-CNN1 reporter system, mir-1274B exerted a similar effect as XBP1s did ( Figure  IXB had an unexpected side effect to induce some factors targeting the mutant-binding sites, resulting in the decreased stability of the mutant reporter mRNA. This caused a significant increase between the pre-mir-1274B and pre-mir-ctl on the mutant pSI-CNN1m1 and pSI-CNN1m2, showing a positive effect of pre-mir-1274B on the mutant reporters ( Figure IXC in the online-only Data Supplement). Chromatin immunoprecipitation assays confirmed that XBP1s bound to the -529 to -290 region of the mir-1274B promoter in the presence of PDGF ( Figure 5F ). As expected, XBP1u also bound to this region, which was decreased by PDGF treatment ( Figure 5F ). These results suggest that XBP1 splicing decreases CNN1 mRNA stability at least, in part, through the upregulation of mir-1274B transcription.
XBP1s Downregulated TGF-β Signaling
We have observed that overexpression of XBP1s not only decreased CNN1 protein level in the infected cells but also in the adjacent cells. This phenomenon suggests that XBP1s may affect the secretion of some factors. To identify the potential factors, proteomics analyses were performed. Conditioned media were collected from Ad-null or Ad-XBP1u or Ad-XBP1s-infected SMCs, followed by concentration and SDS-PAGE separation. Gel bands were subjected to proteomics analysis. 47 We have detected 64 proteins with difference among the infected cells, categorized into 5 groups (Figure X in the online-only Data Supplement). Interestingly, the TGF-βs family was significantly downregulated by XBP1s but not by XBP1u. To confirm the proteomics data and the involvement of TGF-βs in XBP1s-induced SMC proliferation, we first checked the effect of the conditioned medium from SMCs on the TGF-β signaling in human umbilical vein ECs. It has been well established that TGF-βs exert functions through TGF-β receptors-mediated Smad phosphorylation such as Smad2/Smad3, which in turn, translocate into the nucleus with the assistance of the common Smad mediator, Smad4, and direct target gene transcription. 48 Compared with the normal medium, the conditioned medium from Ad-nullinfected SMCs upregulated both Smad2 and Smad3 phosphorylation ( Figure 6A ). However, the conditioned medium from Ad-XBP1s-infected SMCs significantly reduced both Smad2 and Smad3 phosphorylation when compared with that from Ad-null group ( Figure 6A) . Further experiments confirmed that overexpression of XBP1s also decreased the TGF-β signaling in SMCs as revealed by the decrease of both Smad 2 and Smad3 phosphorylation ( Figure 6B ). Quantitative RT-PCR analysis revealed that XBP1s decreased TGF-β1 to TGF-β3 mRNA levels, whereas XBP1u decreased TGF-β1 and TGF-β2 mRNA levels ( Figure XIA in the online-only Data Supplement). Both XBP1u and XBP1s had no effect on the latent TGF-binding protein 1 mRNA level.
TGF-βs are known to suppress SMC proliferation and induce stem/progenitor cells differentiation toward SMC lineage. Thus, we wondered whether the downregulation of TGF-βs contributed to XBP1s-induced SMC proliferation. To test this, the exogenous TGF-βs were included in the proliferation assays. As shown in Figure 6C , TGF-β3 not TGF-β1/TGF-β2 abolished XBP1s-induced SMC proliferation.
Western blot analysis revealed that all 3 TGF-βs upregulated CNN1 protein levels but only TGF-β3 ablated XBP1s-induced CNN1 decrease ( Figure 6D ). Immunofluorescence staining revealed that the TGF-β3 protein level was higher in 
Discussion
Here, we observed that XBP1 expression and splicing were significantly upregulated in SMCs in response to vascular injury and that the neointimal lesions in the injured vessels were markedly reduced in the XBP1-SMC conditional knockout animals, which was related to the decreased numbers of SMC accumulation. As vascular injury triggers platelet aggregation in the injury area, PDGF is released that could activate SMC proliferation, leading to neointima formation. In this study, we demonstrated for the first time that PDGF activated XBP1 splicing through the interaction of PDGFRβ and IRE1α, which was sufficient to increase SMC migration and essential for PDGF-induced SMC proliferation. The spliced XBP1 triggered SMC migration via the PI3K/Akt pathway and activated SMC proliferation through downregulating CNN1 protein level via upregulating mir-1274B-mediated CNN1 mRNA degradation or downregulating TGF-β3 expression and secretion. Thus, these findings provide a novel mechanism on SMC proliferation and neointimal formation.
Vascular injury triggers media SMCs activation and inflammatory reactions. 49 The activated SMCs undergo migration, proliferation, and apoptosis. 50 The rapid response of XBP1 expression and splicing in SMCs to vascular injury suggests that XBP1 may be involved in these processes. Our previous study has demonstrated that XBP1 splicing can contribute to EC apoptosis and atherosclerosis development. 30 However, in this study, we did not observe SMC apoptosis after XBP1s overexpression. The major role of XBP1 in SMC activation may be migration and proliferation. Considering that in vivo is different from in vitro, we cannot exclude that XBP1 splicing may be involved in SMC apoptosis under vascular injury.
SMC migration from the media to the intima and the following proliferation are key steps in the pathogenesis of vascular diseases, such as atherosclerosis. 51 During these processes, the Akt phosphorylation plays a central role. The Akt phosphorylation is derived from the increased PI3K activation or decreased phosphatase and tensin homolog dephosphorylation. 52, 53 Suppression of PI3K reduces neointima formation, 54 whereas suppression of phosphatase and tensin homolog increases SMC hyperplasia. 55 In this study, we found that XBP1 splicing contributed to neointima formation via regulating SMC migration and proliferation. High levels of XBP1 expression and splicing could be detected immediately post vascular injury, whereas XBP1 deficiency in SMC significantly reduced neointima formation. The XBP1s formed a complex with PI3K and Akt, leading to Akt phosphorylation and SMC migration. However, this signaling pathway seemed not involved in XBP1s-induced proliferation. The Akt phosphorylation inhibitor, LY294002, abolished XBP1s-induced SMC migration but exerted no effect on XBP1s-induced proliferation.
PDGF is a well-known mitogenic factor for mature SMC proliferation. 56 Several signaling pathways have been reported to be activated by PDGF/PDGFRβ binding, such as mitogenactivated protein kinases, PI3K/Akt, and basic fibroblast growth factor releasing. 5, 11, 12 In this study, we have identified a novel signaling pathway after PDGF stimulation, that is, the IRE1α-mediated XBP1 splicing. Our hypothesis is that on the binding of PDGF, a vesicle containing PDGF/PDGFRβ may be formed via endocytosis with the cytoplasmic domain of PDGFRβ protruding into cytoplasm. The vesicle traffics to ER membrane where the PDGFRβ cytoplasmic domain binds to IRE1α, activating IRE1α dimerization and autophosphorylation, which in turn triggers XBP1 mRNA splicing. The spliced XBP1 exerts stimulatory effect on SMC proliferation. Knockdown of IRE1α or XBP1 attenuated the basal level and PDGF-induced SMC proliferation, suggesting that IRE1α-mediated XBP1 splicing plays an important role in SMC proliferation. Indeed, disruption of the XBP1 gene in SM22 positive cells significantly retarded cell proliferation in vitro and attenuated vascular injury-induced neointima formation. Taken together, vascular injury increases PDGF release that triggers IRE1α phosphorylation and XBP1 splicing. The spliced XBP1, in turn, activates SMC proliferation, leading to neointima formation.
Different from the vascular endothelial cell growth factor-XBP1 splicing signaling pathway in ECs, 26 XBP1-induced SMC proliferation is independent of Akt, although overexpression of XBP1s itself could upregulate Akt phosphorylation. Deficiency of XBP1 or knockdown of IRE1α had no effect on PDGF-induced Akt phosphorylation. In SMCs, XBP1 splicing actually activates proliferation through downregulating CNN1 protein. Reconstitution of CNN1 protein via Ad-CNN1 gene transfer attenuates XBP1s-induced SMC proliferation, whereas the XBP1-deficient SMCs possess high level of CNN1 proteins with reduced proliferation potency. CNN1 is a basic actin-binding protein, featured as a specific marker for SMC differentiation. 57, 58 CNN1 may contribute to the maintenance of cytoskeleton in SMC, keeping SMCs at the differentiation and quiescent state. Decrease of CNN1 protein may disrupt this cytoskeleton homeostasis, leading to cell activation. Indeed, reduced level of CNN1 protein was observed in tumor cells and proliferating SMCs, whereas upregulation of CNN1 suppressed SMC proliferation. 18, 59, 60 Our study also confirmed the negative relationship between CNN1 protein level and SMC proliferation. The slowly proliferating XBP1-deficient cells possessed higher level of CNN1, and overexpression of CNN1 via Ad-CNN1 gene transfer reduced SMC proliferation. The XBP1 splicing plays an essential negative regulating role in CNN1 expression. Overexpression of XBP1s downregulated CNN1 at mRNA and protein levels, whereas XBP1 or IRE1α deficiency abolished PDGF-induced downregulation of CNN1 protein. Robust level of CNN1 protein was observed in the XBP1 knockout SMCs. Being a transcription factor, XBP1s seems not involved in CNN1 transcription. Actually, XBP1s regulates CNN1 mRNA stability via upregulation of mir-1274B and CNN1 protein stability. In the latter process, TGF-β3 may be involved.
miRNAs were identified as negative regulators of mRNA stability or protein translation in the past decade, mainly targeting the 3′-UTR of mRNA molecules. 61 In this study, we found that XBP1s upregulated and downregulated several miRNAs in SMCs, among which mir-1274B seemed involved in CNN1 mRNA stability regulation. Transfection of the mir-1274B mimics downregulated CNN1 mRNA. The mir-1274B could also be secreted into culture medium, which might function as a paracrine factor to downregulate CNN1 mRNA in the adjacent cells. The mir-1274B was originally identified from a genome sequencing project, sharing structure with tRNA (lys3). 62 Recent studies showed that mir-1274B was upregulated in cutaneous malignant melanoma while downregulated in chemoradiotherapy-treated advanced rectal cancer, implying that mir-1274B may be related to tumor growth. 63, 64 Report from Shinozuka et al 65 showed that mir-1274B was regulated by SnoN/SKIL and negatively related to esophageal cancer cell proliferation. In this study, we demonstrate that CNN1 is a target of mir-1274B, and that XBP1s is involved in the transcriptional regulation of mir-1274B. Chromatin immunoprecipitation assay revealed that XBP1s directly bound to the −520 to −290 region in mir-1274B promoter.
TGF-β is a superfamily of growth factors, exerting diverse roles in different cell types. It is well established that TGF-βs stimulate stem/progenitor cells differentiation toward SMCs. 66 In this study, we found that XBP1s downregulated the TGF-β1 to TGF-β3 mRNA levels, TGF-β signaling and TGF-βs secretion in SMCs. Thus, the XBP1s-induced SMC proliferation may be because of the decrease of TGF-β-mediated differentiation in part. As expected, all the 3 TGF-βs upregulated the CNN1 protein level, suggesting their differentiation roles. However, only TGF-β3 could antagonize XBP1s-induced CNN1 decrease and SMC proliferation. Therefore, TGF-β3 may cross talk with XBP1s to regulate SMC differentiation and proliferation. As proteasome inhibitor ALLN has similar effect as TGF-β3, there may be cross talk between TGF-β3 and proteasome activation. However, the underlying mechanisms in this cross talk need further investigation.
In summary, vascular injury may trigger PDGF release in the injured area. On SMCs, PDGF binds to PDGFRβ, leading to PDGFRβ interaction with IRE1α, which in turn activates IRE1α phosphorylation and XBP1 mRNA splicing. On one hand, XBP1s activates the PI3K/Akt pathway, increasing SMC migration. On the other hand, XBP1s activates the transcription of mir-1274B that targets and increases CNN1 mRNA degradation, leading to the decrease of CNN1 protein and SMC proliferation. The overall effect contributes to the neointima formation ( Figure XII in the online-only Data Supplement).
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